SCHEMBL879358

SCHEMBL879358

CC(=O)c1cc(I)cc(I)c1I

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.46
POLB P06746 2/20 0.40
NLRP3 Q96P20 1/20 0.40
TPMT P51580 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
ERN1 O75460 1/20 0.34
MAOB P27338 1/20 0.34
HTT P42858 1/20 0.33
CYP3A4 P08684 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15368352 0.82 SMN1; SMN2 (0.40) TTRPOLBNLRP3TPMTSMN1; SMN2
SCHEMBL22991362 0.82 TTR (0.61) TTRPOLBNLRP3SMN1; SMN2ERN1
SCHEMBL22014369 0.82 TTR (0.42) TTRPOLBNLRP3TPMTHDAC3
2,3,5-Triiodobenzoic Acid SCHEMBL39041 0.81 TPMT (0.50) TTRPOLBNLRP3TPMTHDAC3
SCHEMBL12966232 0.79 HDAC3 (0.41) TTRPOLBNLRP3TPMTHDAC3
SCHEMBL22991599 0.79 TTR (0.50) TTRPOLBNLRP3HDAC3HDAC4
SCHEMBL29367522 0.79 TTR (0.39) TTRPOLBNLRP3TPMTHDAC3
2,3,5-Triiodobenzoic Acid SCHEMBL23524593 0.79 TPMT (0.48) TTRPOLBNLRP3TPMTHDAC3
SCHEMBL879357 0.79 TTR (0.39) TTRPOLBNLRP3TPMTHDAC3
SCHEMBL29595299 0.79 HDAC3 (0.41) TTRPOLBNLRP3TPMTHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023140231-A1 RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, AND COMPOUND 東京応化工業株式会社 2023-07-27 WO disclosed
WO-2020228627-A1 NOVEL BIMODAL SMALL MOLECULE CONTRAST AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 南京鼓楼医院 2020-11-19 WO disclosed
US-8574550-B2 Biocompatible polymeric contrast agents and radiopaque materials for medical services CORDIS CORPORATION 2013-11-05 US disclosed
US-8197796-B2 organic high intensity X-ray contrast agents, dispersed within or conjugated biodegradable polymers, suitable for enhancing the imaging of medical devices, particularly polymeric medical devices and polymeric coatings CORDIS CORPORATION 2012-06-12 US disclosed
EP-1815871-B1 Radiographic contrasting agents and radio-opaque polymeric materials for medical devices CORDIS CORP (US) 2012-03-28 EP disclosed
US-7771705-B2 Radiographic contrasting agents and radio-opaque polymeric materials for medical devices CORDIS CORPORATION (US) 2010-08-10 US disclosed
US-7704488-B2 Dendritic and star-shaped contrast agents for medical devices and bioabsorbable radiopaque bulk material and method for producing same CORDIS CORPORATION (US) 2010-04-27 US disclosed
US-20090209745-A1 RADIOGRAPHIC CONTRASTING AGENTS AND RADIO-OPAQUE POLYMERIC MATERIALS FOR MEDICAL DEVICES CORDIS US CORP 2009-08-20 US disclosed
US-20080275210-A1 BIOCOMPATIBLE POLYMERIC CONTRAST AGENTS AND RADIOPAQUE MATERIALS FOR MEDICAL DEVICES CORDIS US CORP 2008-11-06 US disclosed
US-20080177102-A1 DENDRITIC AND STAR-SHAPED CONTRAST AGENTS FOR MEDICAL DEVICES AND BIOABSORBABLE RADIOPAQUE BULK MATERIAL AND METHOD FOR PRODUCING SAME CORDIS US CORP 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080177102-A1 DENDRITIC AND STAR-SHAPED CONTRAST AGENTS FOR MEDICAL DEVICES AND BIOABSORBABLE RADIOPAQUE BULK MATERIAL AND METHOD FOR PRODUCING SAME MSR1, MYD88, CD209 TTR 4695/4885POLB 2721/4885NLRP3 1908/4885
US-20090209745-A1 RADIOGRAPHIC CONTRASTING AGENTS AND RADIO-OPAQUE POLYMERIC MATERIALS FOR MEDICAL DEVICES MYADM, PBRM1, RXFP3 TTR 2900/4885POLB 3268/4885NLRP3 653/4885
US-20080275210-A1 BIOCOMPATIBLE POLYMERIC CONTRAST AGENTS AND RADIOPAQUE MATERIALS FOR MEDICAL DEVICES CD68, TLR9, PBRM1 TTR 4506/4885POLB 1886/4885NLRP3 2063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.